Overview

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Status:
Recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Universität des Saarlandes
Collaborators:
Bristol-Myers Squibb
Lymphoma Study Association
University of Leipzig
Treatments:
Gemcitabine
Nivolumab
Oxaliplatin
Rituximab